Chelsea Therapeutics Intl Ltd fka CHIP

[Tecumseh]

From New Edva Artcile: "Shares pulled back yesterday on a Seeking Alpha article which seemed to dim prospects of market penetration, adoption by the medical community and so on. People need to understand that there is no other option for this condition and there is no limitation of prescription which is what was feared, not by us but from numerous quarters spreading FUD. One strategy I see is that of averaging down or adding if you held or opening a new position if you sold. I see a partner or a buyout in the future and I take some of the analyst opinions that I have read in that vein as instructive. While some have complained about what they consider to be lack of communication from the company, I am actually heartened by it in this age of over-communication. There is no need for hand holding here folks. I assume (and yes it is an assumption) that CHTP management is in serious discussions regarding its next steps and has been well before they gained FDA approval for Northera. The stock is now trading at pre-approval levels so we consider it to be a pretty strong buy. Like PLUG, there is time sensitivity here as we think that news of a partnership or buyout may be imminent."